Free Newsletter
SPOTLIGHT: Daiichi Sankyo buys OTC business
Daiichi Sankyo has inked a deal to buy the OTC unit of Astellas--Zepharma--for 20 billion yen. Report
Daiichi Sankyo has inked a deal to buy the OTC unit of Astellas--Zepharma--for 20 billion yen. Report
Click here to get the FierceBiotech email newsletter for FREE!